GBA's "2021 Stock Phantasma"

Discussion in 'Stocks' started by stonedinvestor, Jan 1, 2021.

  1. vanzandt

    vanzandt

    I'm not daytrading some stupid non-marginable IPO that's not available to short or has no option chains.

    Its at $31... watch the bottom fall out.
     
    #5681     Jun 11, 2021
  2. vanzandt

    vanzandt

    30.85 and falling
     
    #5682     Jun 11, 2021
  3. janes

    janes

    31.70 and rising. sorry. stoney wasn't here to say it so i thought i should say it in absentia.
     
    #5683     Jun 11, 2021
    vanzandt likes this.
  4. vanzandt

    vanzandt

    Well give it a few.
    Its not marginable... so wait till the whales move on.
     
    #5684     Jun 11, 2021
  5. janes

    janes

    30.55 and falling. the secret sauce to this thread is paying attention to the stocks that you both like.
     
    #5685     Jun 11, 2021
    vanzandt and Centuria100 like this.
  6. vanzandt

    vanzandt

    It's already down 10% from 1st mention Stoney.
    See, those guys from hedge fund were right.
    10% is 10%
     
    #5686     Jun 11, 2021
  7. Affirm Holdings, Inc. (AFRM)-wow just wow -who listened when I gave you the reason it would move.....!!!
    NasdaqGS - NasdaqGS Real Time Price. Currency in USD
    $68.27+4.59 (+7.21%)
    As of 2:24PM EDT.
     
    #5687     Jun 11, 2021
    Centuria100 likes this.
  8. Van sorry I don't know options. MQ should finish even higher. Up almost 5% I sent email to HF request for their blessing... But I told them I was interested in entering next week.

    In a tough spot because that wage inflation number is going to take everything down hard.

    When can we buy and feel like we can hold through the summer.
     
    #5688     Jun 11, 2021
  9. Big problems at FDA. Swaths of boards resigned they passed that Biogen drug when they shouldn't have. I have ton of that in one account. This is going to be very bad for all of biotech. People are already not trusting authorities because of their dumb ass thinking about Fauchi & vaccines. Not good.
     
    #5689     Jun 11, 2021
  10. Products/Pipeline
    Berkeley Lights' core offering is their fully integrated end-to-end single-cell analytics platform which covers proprietary consumables including their OptoSelect chips, reagent kits, advanced automation systems, and application/workflow software all for sale covering product and service revenue segments.

    [​IMG]

    Source: Berkeley Lights

    This platform technology utilizes "NanoPen" chambers which are 100,000x smaller in volume than a microwell and can functionally characterize single cells in parallel across 10K+ chambers (wells) functioning in large part by advanced microfluidics, a complex technology for moving micro-sized items (e.g. a single cell) around various chambers via light-activation (a simplified example for those unfamiliar with basic microfluidics).

    [​IMG]

    Graphic Source: Berkeley Lights

    The light-activation aspect, termed Opto-ElectroPositioning ("OEP"), enables deterministic positioning of living single cells and other micro-objects using light allowing for an impressive level of control over single-cells and micro-objects in their NanoPen chambers (expanded explanation). The result is the ability to assay single cells in minutes and derive hundreds of data points for various single-cell lines including single-cell growth rates, surface markers, IgG secretion, correlating killing activity of single CAR T cells, cytokine secretion, proliferation, gene expression, cell-cell interactions, RNA-expression, and more, all with the ability to recover the successful live-cell lines and products.

    [​IMG]
     
    #5690     Jun 11, 2021